Medical Component Manufacturing Market Report 2026

The medical component manufacturing market size has grown strongly in recent years. It will grow from $15.13 billion in 2025 to $16.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growth in medical device production, increasing demand for surgical instruments, expansion of hospital infrastructure, early outsourcing of component manufacturing, rising need for standardized medical parts.

The medical component manufacturing market size is expected to see strong growth in the next few years. It will grow to $21.87 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing adoption of minimally invasive procedures, rising demand for implantable devices, growth of additive manufacturing in healthcare, increasing regulatory scrutiny on component quality, expansion of global medical device markets. Major trends in the forecast period include rising demand for precision-manufactured medical components, increasing adoption of advanced manufacturing processes, growing focus on miniaturization of medical device parts, expansion of custom and application-specific component production, higher emphasis on quality compliance and traceability.

The increasing demand for medical devices is fueling the growth of the medical component manufacturing market in the coming years. Medical devices include instruments, machines, appliances, software, implants, or other similar articles used for diagnosing, preventing, monitoring, treating, or alleviating diseases or medical conditions in humans. Medical component manufacturing involves producing components such as injection-molded parts and electronic elements used in medical devices. For example, in July 2024, the American Hospital Association, a US-based professional organization, reported that medical-equipment (device) imports had reached US$ 14.9 billion, compared with US$ 14.0 billion during the same period in 2023, indicating steady year-over-year growth in demand for medical devices. Thus, the rising demand for medical devices is driving the medical component manufacturing market.

Major companies in the medical component manufacturing market are focusing on developing advanced technologies such as metal injection molding, which improves precision and minimizes production waste. Metal injection molding is a manufacturing process that merges injection molding with powder metallurgy to create complex, high-precision metal parts by injecting a mixture of metal powder and polymer into a mold. For example, in October 2024, Biomerics, a US-based medical equipment manufacturer, introduced vertically integrated metal injection molding (MIM) services. This new MIM service, offered through a Center of Excellence, enhances the ability to produce complex, high-performance interventional medical devices.

In July 2024, DuPont de Nemours, Inc., a US-based materials science company, acquired Donatelle Plastics, Inc. for $313 million. With this acquisition, DuPont de Nemours, Inc. aims to strengthen its presence in the high-growth medical device market and reinforce its position as a preferred partner for medical device OEMs. Donatelle Plastics, Inc. is a US-based contract manufacturer specializing in medical components and devices, including surgical staplers, feeding tubes, and other injection-molded and silicone-based medical products.

Major companies operating in the medical component manufacturing market are Johnson & Johnson Services Inc., Abbott Laboratories Inc., 3M Company, Heraeus Holding GmbH, Medtronic plc, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips NV, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Olympus Corporation, The Lubrizol Corporation, Intuitive Surgical Inc., Terumo Corporation, Varian Medical Systems Inc., West Pharmaceutical Services Inc., The Ensinger Group, 3D Systems Inc., Hudson Technologies Inc., Seisa Medical Inc, Viant Medical Inc., Anchor Harvey Components LLC, The Rodon Group, Nexxt Spine LLC, Hologic Inc., American Casting Company, Optimum Medical Limited, Walter Stern Inc.

North America was the largest region in the medical component manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical component manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical component manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs impact the medical component manufacturing market by increasing the cost of imported raw materials, precision tooling, and advanced manufacturing equipment. These effects are more pronounced in regions reliant on cross-border supply chains, particularly asia-pacific and europe. Higher production costs can pressure margins for component manufacturers and medical device OEMs. However, tariffs also encourage domestic sourcing and local manufacturing, strengthening regional supply chains and reducing dependency on imports.

The medical component manufacturing market research report is one of a series of new reports that provides medical component manufacturing market statistics, including medical component manufacturing industry global market size, regional shares, competitors with a medical component manufacturing market share, detailed medical component manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the medical component manufacturing industry. This medical component manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical component manufacturing involves producing individual parts or elements used in the creation of medical devices, instruments, and equipment for healthcare purposes. It provides components for a variety of medical applications, including surgical instruments, implantable devices, diagnostic equipment, and more.

The primary methods of medical component manufacturing include forging, metal injection molding, 3D printing, ceramic injection molding, investment casting, plastic injection molding, among others. Forging is the process of shaping metal by applying localized compressive forces. The range of services includes device development and manufacturing, quality management, and final product assembly, applied across fields such as laparoscopy, pulmonary, urology and gynecology, cardiovascular, orthopedic, oncology, neurovascular, radiology, and more.

The medical component manufacturing market consists of sales of neuromonitoring devices, surgical video systems, and imaging systems, cry lipolysis equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.